Leidos (LDOS) Q4 2025: Book-to-Bill Holds at 1.3x, $20B Pending Awards Signal Growth Acceleration
Leidos capped a volatile year by sustaining a 1.3x book-to-bill and building a $20 billion pending award pipeline, positioning the company for accelerating growth in 2026 despite Q4 revenue headwinds. Strategic investments in defense tech, cyber, and energy engineering are driving a portfolio shift toward higher-margin, mission-critical programs. Management’s capital allocation is pivoting to organic and inorganic growth, with CapEx tripling and M&A set to reshape the business mix for the decade ahead.
Summary
- Record Pipeline Momentum: $20 billion in pending awards and back-to-back 1.3x book-to-bill underpin growth trajectory.
- Strategic Portfolio Shift: Defense, cyber, and energy investments realign Leidos toward higher-value, resilient segments.
- CapEx and M&A Pivot: Tripled capital spend and Entrust acquisition mark a decisive move to scale growth pillars.
Performance Analysis
Leidos ended 2025 navigating a complex federal contracting environment, marked by a six-week U.S. government shutdown and an extra work week in 2024, both distorting headline growth rates. After normalizing for these factors, Q4 revenue would have grown approximately 4% year over year, reflecting underlying demand strength, especially in integrated air defense, intelligence, and energy infrastructure.
Margin expansion was a standout, with adjusted EBITDA margin up 120 basis points for the year and 160 basis points in Q4, benefiting from a more profitable business mix and disciplined execution. All four segments contributed to revenue growth for the year, with the defense segment showing the most robust margin improvement as key programs moved into production. Free cash flow conversion remained strong, supported by operational discipline and $150 million in Section 174 tax savings, enabling record cash generation and continued shareholder distributions.
- Defense Segment Leverage: Accelerated production in defense tech and munitions drove outsized margin gains in Q4.
- Commercial & International Resilience: UK and Australia operations offset legacy asset divestiture, with AI adoption boosting grid engineering productivity.
- Health Segment Transition: Managed health services faced near-term headwinds, but profitability remains robust above 20% as the business pivots to rural and behavioral health.
Leidos’ ability to outperform guidance and deliver double-digit EPS and cash flow growth for a third consecutive year signals a structural improvement in its operating model, even as near-term revenue optics remain clouded by calendar effects and federal funding lags.
Executive Commentary
"We are redefining what it means to be a national security company, and we are excited to be accelerating outcomes. So we are now firmly in strategy execution mode for our North Star 2030 strategy with a strong bias for velocity and a strong productive sense of urgency."
Tom Bell, Chief Executive Officer
"Our margin expansion journey has meaningfully changed how we view what is possible, and that change permeates the entire company. The sectors are more focused on program execution, with six consecutive quarters of positive net EACs, and all of our functional organizations are continually pursuing operating efficiencies."
Chris Cage, Chief Financial Officer
Strategic Positioning
1. Growth Pillar Acceleration
Leidos is doubling down on its North Star 2030 strategy, prioritizing defense tech, cyber, energy engineering, and managed health as core growth pillars. Notable wins in passive radar, cloud architecture, and key IDIQs (Indefinite Delivery, Indefinite Quantity contracts, which provide flexible, multi-year funding vehicles) provide visibility into multi-year demand and validate years of IRAD (Internal Research and Development) investment. The company’s $350 million CapEx plan for 2026 targets scaling production, classified facility upgrades, and co-investment opportunities with government agencies.
2. Portfolio Realignment and M&A
Recent acquisitions and divestitures reflect a deliberate portfolio shift. The Kudu Dynamics acquisition enhanced cyber capabilities and market access, while the Entrust Solutions Group deal is set to create a U.S. power engineering leader, unlocking cross-sell and margin synergies. The VARIC divestiture trimmed legacy exposure. Management is clear that capital deployment will increasingly favor organic and inorganic growth, with share buybacks deprioritized in favor of strategic investments.
3. Segment Reorganization for Execution
Leidos has realigned into five operating sectors, consolidated into four reporting segments—Defense, Homeland, Intelligence & Digital, and Health—to better match growth priorities and customer missions. This structure aims to sharpen focus on defense integration, homeland security, cyber innovation, and health transformation, with leadership changes bringing fresh execution discipline and technical vision.
4. Technology and AI Integration
AI is positioned as a force multiplier, not a margin threat. The company’s “AI-first” philosophy is being embedded both internally and in customer solutions, with the transformation office tasked to deliver measurable cost reductions and prototype efficiencies for government clients. Leadership sees AI as a lever to shift budgets from maintenance to high-value mission outcomes, especially in digital modernization and grid engineering.
5. Backlog and Pipeline Visibility
Back-to-back 1.3x book-to-bill ratios, a 15% increase in funded backlog, and $20 billion in pending awards provide strong revenue visibility into 2026 and beyond. Management notes that the pipeline is weighted toward new business and takeaways, and that delayed government awards from Q4 are expected to convert to execution as the year progresses, supporting the anticipated growth ramp in the second half of 2026.
Key Considerations
Leidos’ quarter demonstrates a decisive pivot toward high-growth, high-margin government technology domains, underpinned by a robust pipeline and strategic capital allocation. The company is balancing near-term execution with long-term transformation.
Key Considerations:
- Pending Award Conversion: $7 billion in delayed Q4 awards and $20 billion in pending proposals are critical to fueling second-half 2026 growth acceleration.
- Health Segment Inflection: Managed health faces near-term margin pressure from re-competes and vendor share shifts, but rural and behavioral health expansion offers a structural growth path.
- CapEx and Working Capital Discipline: Tripled CapEx is targeted at scaling awarded programs, with a focus on maintaining strong cash returns through working capital optimization.
- Defense and Maritime Upside: Success in programs of record like IFPC and MUSV (Medium Unmanned Surface Vessels) could unlock substantial multi-year growth, but timing of government decisions remains a gating factor.
Risks
Execution risk remains around the timing and conversion of large pending awards, especially given federal budget cycles and potential for further delays. Margin sustainability depends on continued mix shift to higher-value programs and successful integration of recent acquisitions. The health segment faces competitive pressure from new entrants and re-compete pricing. Macro and regulatory uncertainties, including further shutdowns or funding disruptions, could introduce volatility.
Forward Outlook
For Q1 and full-year 2026, Leidos guided to:
- Revenue of $17.5–$17.9 billion, implying up to 4% growth with a second-half acceleration approaching double digits.
- Adjusted EBITDA margin in the “mid-13s” percent range, normalizing from 2025’s one-time benefits.
- Non-GAAP EPS of $12.05–$12.45, with $200 million in interest expense and a 24% effective tax rate.
- Operating cash flow of $1.75 billion, with free cash flow modestly down due to the $350 million CapEx ramp.
Management expects revenue growth to build through the year as delayed awards and new program wins move into execution, with upside potential from FAA modernization, Golden Dome, and defense tech ramp-ups. Guidance excludes any Entrust contribution, to be updated post-close.
Takeaways
Leidos is entering 2026 with record backlog momentum and a clear pivot to growth pillars—defense, cyber, energy, and health—supported by disciplined capital allocation and operational realignment.
- Pipeline Conversion Is Critical: The $20 billion pending award book must translate to revenue to realize the anticipated second-half growth ramp.
- Portfolio Transformation Underway: Recent M&A and divestitures are reshaping the business toward higher-margin, mission-critical domains.
- Watch for Segment Inflections: Defense and intelligence offer near-term growth, while health and homeland segments could inflect as new government priorities and awards materialize.
Conclusion
Leidos’ Q4 and FY25 results highlight a business in transition, leveraging a robust pipeline, margin expansion, and targeted investments to reposition for outsized growth in 2026 and beyond. The ability to convert backlog and pending awards into execution will determine if the North Star 2030 strategy delivers on its promise of sustained outperformance.
Industry Read-Through
The sustained 1.3x book-to-bill and record pending award pipeline at Leidos signal that federal technology and defense demand remains robust, even as funding lags and shutdowns create near-term noise. The pivot to AI-enabled solutions, cyber, and energy infrastructure mirrors broader industry trends, suggesting competitors must accelerate innovation and portfolio realignment to capture similar growth. Margin expansion through disciplined program execution and business mix improvement is increasingly a differentiator for government services peers. The M&A and CapEx pivot at Leidos sets a precedent for sector capital allocation as the defense and government IT landscape evolves toward scale and technology integration.